Graduate School of health and Medical Sciences

Biobanking in the era of personalised medicine
Provider: Faculty of Health and Medical Sciences

Activity no.: 3687-21-00-00
	Enrollment deadline: 17/10/2021

Date and time	15.11.2021, at: 09:00 - 19.11.2021, at: 17:00
Regular seats	20
Course fee	6,720.00 kr.
Lecturers	Lasse Boding
ECTS credits	3.50

Contact person	Anne Vitoft E-mail address: avt@ssi.dk

Enrolment Handling/Course Organiser	PhD administration E-mail address: phdkursus@sund.ku.dk

Aim and content This course is free of charge for PhD students at Danish universities (except Copenhagen Business School), and for PhD students at graduate schools in the other Nordic countries. All other participants must pay the course fee. Anyone can apply for the course, but if you are not a PhD student at a Danish university, you will be placed on the waiting list until enrollment deadline. This also applies to PhD students from Nordic countries. After the enrollment deadline, available seats will be allocated to applicants on the waiting list. Learning objectives A student who has met the objectives of the course will be able to: 1. Understand the many facets of modern biobanking and the link to personalised medicine 2. Be able to apply for required ethical and data approvals 3. Undertake a solid research project based on biobank samples 4. Discuss the ELSI aspects (ethical, legal and societal implications) of biobanking 5. See the patients perspective and how biobanking research impacts on the society Content The objective of this 5-day PhD course is to give insights and later deepen the student’s understanding in the multidisciplinary world of biobanking. Offered as a collaboration between Copenhagen and Lund Universities and with the collaboration of Danish National Biobank, University of Helsinki and The Spanish National Cancer Research Centre, the course aims to provide the students with a core set of tools to gain better understanding of the key role of biobanking in translational medicine. The goal is to provide an interdisciplinary perspective on the historical, philosophical, ethical, legal, social, technical and cultural aspects related to the collection, storage, use and dissemination of human biological samples and health information. After completion of the course, the students will have a broad understanding of biobanking, as well as the challenges associated with collaboration between the different stakeholders. The course also offers a site visit to the Danish National Biobank. Participants PhD students with an interest in biobanking, personalised medicine and related research Relevance to graduate programmes The course is relevant to PhD students from the following graduate programmes at the Graduate School of Health and Medical Sciences, UCPH: All graduate programmes Language English Form 5-day intensive seminar which includes a 2-day symposium and onsite visit to the Danish National Biobank (Copenhagen). Assigned reading package, active participation in class discussions and working groups, course assignment in working group (oral presentation). Course director Lasse Boding, PhD, Head of Unit, Danish National Biobank, Statens Serum Institut, labo@ssi.dk Teachers Lasse Boding, Head of Unit, Danish National Biobank, Statens Serum Institut Eva Ortega-Paino, Research Director, Spanish National Cancer Institute Bart Wilkowski, Head of IT, Danish National Biobank Aaro Tupasela, Docent, University of Helsinki Peter Nilsson, Professor, Lund University Alexander Lind, Postdoc, Lund University Mette Hartlev, Professor University of Copenhagen Johan Modin, Director, Swedish Ethical Review Authority Klaus Høyer, Professor, University of Copenhagen Marina Pollan, Professor, Health Institute Carlos III, Madrid Peter Garred, Professor, University of Copenhagen Niels Tommerup, Professor, University of Copenhagen Tune Pers, Associate Professor, University of Copenhagen Søren Brunak, Professor, University of Copenhagen Marco Hautalahti, CEO, Finnish Biobanks Cooperative (FINBB), Finland Frederik Knud Nielsen, Strategic Pipeline Lead, Novartis Marianne Pilgaard, CEO, Trial Nation Lila Kallio, Director, Auria Biobank, Turku, Finland Jens Habermann, Director General, BBMRI-ERIC Sandra Liede, Lawyer, Healthtech Finland Jakob Bjerg Larsen, Head of Clinical Trials and and Pharmaceutical Manufacturing Policy, The Danish Association of the Pharmaceutical Industry (LIF) Dates 15 - 19 November 2021 All days 9 - 17 Course location Copenhagen Registration Please register before 17 October 2021 Seats to PhD students from other Danish universities will be allocated on a first-come, first-served basis and according to the applicable rules. Applications from other participants will be considered after the last day of enrolment. Note: All applicants are asked to submit invoice details in case of no-show, late cancellation or obligation to pay the course fee (typically non-PhD students). If you are a PhD student, your participation in the course must be in agreement with your principal supervisor.

Click the search button to search Courses.

See which courses you can attend and when

Jan	Feb	Mar	Apr
May	Jun	Jul	Aug
Sep	Oct	Nov	Dec

New courses
Courses are published regularly. High demand courses are announced in spring and autumn.

Learn which courses are announced on fixed dates